Corvus Pharmaceuticals Inc (NASDAQ:CRVS)

0.9997
Delayed Data
As of May 25
 +0.0329 / +3.40%
Today’s Change
0.94
Today|||52-Week Range
9.54
-58.52%
Year-to-Date

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for Corvus Pharmaceuticals Inc have a median target of 6.00, with a high estimate of 8.00 and a low estimate of 3.50. The median estimate represents a +500.18% increase from the last price of 1.00.

Analyst Recommendations

The current consensus among 3 polled investment analysts is to Buy stock in Corvus Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.18
Sales
$0.00
Reporting Date
Aug 04

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 1.85%
 
 
 
 
 
 
Growthannually 18.45%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.